Cargando…
A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results
A typical rule that has been used for the endorsement of new medications by the Food and Drug Administration is to have two trials, each convincing on its own, demonstrating effectiveness. “Convincing” may be subjectively interpreted, but the use of p-values and the focus on statistical significance...
Autores principales: | van Ravenzwaaij, Don, Ioannidis, John P. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342224/ https://www.ncbi.nlm.nih.gov/pubmed/28273140 http://dx.doi.org/10.1371/journal.pone.0173184 |
Ejemplares similares
-
True and false positive rates for different criteria of evaluating statistical evidence from clinical trials
por: van Ravenzwaaij, Don, et al.
Publicado: (2019) -
Bayesian reanalysis of null results reported in medicine: Strong yet variable evidence for the absence of treatment effects
por: Hoekstra, Rink, et al.
Publicado: (2018) -
Bayes factors for superiority, non-inferiority, and equivalence designs
por: van Ravenzwaaij, Don, et al.
Publicado: (2019) -
How best to quantify replication success? A simulation study on the comparison of replication success metrics
por: Muradchanian, Jasmine, et al.
Publicado: (2021) -
Comparing the evidential strength for psychotropic drugs: a Bayesian meta-analysis
por: Pittelkow, Merle-Marie, et al.
Publicado: (2021)